Goldtrack Ventures Launches $250M Biotech Fund to Boost Saudi Innovation

Editorial Team

Last updated 28-10-2025

3 min

Goldtrack Ventures launches a $250 million fund for industrial biotech in Saudi Arabia.

The fund aims to support early-stage and growth-phase biotech companies in the MENA region.

Registration with Saudi Arabia’s CMA is planned before 2025; investments start in 2026.

Focus is on sustainable commercialisation, aligning with Saudi’s broader development goals.

Regional funds increasingly support biotech, highlighting MENA's maturing startup scene.

Goldtrack Ventures has just unveiled plans for a hefty $250 million growth fund aimed squarely at the industrial biotechnology scene in Saudi Arabia. The move was announced during the Global Health Exhibition in Riyadh — a fitting stage, if you ask me, given how much buzz biotech is creating across the region lately.

The new fund is designed to help scale the biotech innovation ecosystem by backing both early-stage and growth-phase companies inside the Kingdom and across the wider MENA region. On top of that, Goldtrack Ventures wants to push outward — forming scientific and industrial partnerships beyond its borders to give Saudi-born innovation a genuinely global edge. I reckon that’s a smart call; collaboration is half the game in biotech these days.

For now, the company is busy structuring the fund, with a plan to have it officially registered with Saudi Arabia’s Capital Market Authority (CMA) before the end of 2025. First investments, though, aren’t expected before 2026, so we’ve got a little while to wait before the cash starts flowing. Still, patience in this field often pays off — good science isn’t exactly built overnight.

What caught my eye is how clearly the fund aligns with the Kingdom’s broader development goals, pushing sustainability and industrial innovation hand in hand. The focus will be on scalable commercialisation — or, simply put, turning lab breakthroughs into viable, industrial-scale products. And believe it or not, that’s no small feat; it takes years of research, testing, and regulation. But with a bit of savvy and a lot of perseverance, Saudi’s homegrown biotech players could be on to something big.

Here at Arageek, we’ve seen more regional funds dipping their toes into biotech lately — from Abu Dhabi’s Hub71+ Life Sciences initiative to smaller research accelerators popping up across the Gulf. It reminds me of a chat I once had with a young founder in Jeddah who described fundraising as “a bit of a faff but worth every sleepless night.” That same relentless drive is exactly what this new fund hopes to tap into.

If it all goes to plan, Goldtrack’s $250 million push could very well give the region’s biotech ecosystem the shot in the arm it needs (pun intended). And honestly, I’m quite chuffed to see yet another serious bet being placed on local innovation — definately a sign the MENA startup scene is maturing fast.

🚀 Got exciting news to share?

If you're a startup founder, VC, or PR agency with big updates—funding rounds, product launches 📢, or company milestones 🎉 — AraGeek English wants to hear from you!